EUVIMEDEUVIMED entdecken
Open Access

Dendrimer Gel Nanoparticles with Dual-Targeting of uPAR and Ribonucleotide Reductase R2 Influence Necrosis, Apoptosis, and Cell Cycle Arrest in Triple-Negative Breast Cancer

Hsin-Yin Chuang iD, Yue-Wern Huang iD, Hu Yang iD

Molecular Pharmaceutics · 01.12.2025 · 22 (12) · 7620-7629

DOI: 10.1021/acs.molpharmaceut.5c01209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 11.11.2025. Verfasst von Hsin-Yin Chuang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Linda and Bipin Doshi Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, Missouri 65409, Unite…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Dendrimers, Apoptosis, Cell Cycle Checkpoints. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Clinical Center, Missouri S&T Kummer Initiation Grant Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDendrimersApoptosisCell Cycle CheckpointsReceptors, Urokinase Plasminogen ActivatorNanoparticlesRibonucleoside Diphosphate ReductaseHumansFemaleCell Line, TumorNecrosisAnimalsMiceMice, NudeXenograft Model Antitumor Assays

Stichwörter der Autor:innen

apoptosiscell cycle arrestnanomedicineribonucleotide reductasetargeted gene deliveryurokinase-type plasminogen activator receptor

Substanzen

DendrimersReceptors, Urokinase Plasminogen ActivatorRibonucleoside Diphosphate ReductasePAMAM Starburst

Autor:innen und Institutionen

  • Linda and Bipin Doshi Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, Missouri 65409, United States.
  • Department of Biological Sciences, Missouri University of Science and Technology, Rolla, Missouri 65409, United States.
  • Joint Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.

ORCID-Profile: Hsin-Yin Chuang, Yue-Wern Huang, Hu Yang

Förderung

  • NHLBI NIH HHS
  • Clinical Center
  • Missouri S&T Kummer Initiation Grant Initiative
  • Ozark Biomedical Initiative grant
  • Center for Biomedical Research in S&T
  • Kummer Innovation and Entrepreneurship Doctoral Fellowship in Missouri S&T

Zitieren

APA

Chuang, H. Y., Huang, Y. W., & Yang, H. (2025). Dendrimer Gel Nanoparticles with Dual-Targeting of uPAR and Ribonucleotide Reductase R2 Influence Necrosis, Apoptosis, and Cell Cycle Arrest in Triple-Negative Breast Cancer. Molecular Pharmaceutics, 22(12), 7620-7629. https://doi.org/10.1021/acs.molpharmaceut.5c01209

Vancouver

Chuang HY, Huang YW, Yang H. Dendrimer Gel Nanoparticles with Dual-Targeting of uPAR and Ribonucleotide Reductase R2 Influence Necrosis, Apoptosis, and Cell Cycle Arrest in Triple-Negative Breast Cancer. Molecular Pharmaceutics. 2025;22(12):7620-7629. doi:10.1021/acs.molpharmaceut.5c01209

BibTeX
@article{Chuang2025,
  author = {Chuang, Hsin-Yin and Huang, Yue-Wern and Yang, Hu},
  title = {Dendrimer Gel Nanoparticles with Dual-Targeting of uPAR and Ribonucleotide Reductase R2 Influence Necrosis, Apoptosis, and Cell Cycle Arrest in Triple-Negative Breast Cancer},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {12},
  pages = {7620--7629},
  doi = {10.1021/acs.molpharmaceut.5c01209}
}
Kostenlos starten →